Novartis, a Swiss multinational pharmaceutical corporation, announced it plans to make a $23 billion investment over five years in U.S.-based infrastructure.
In a press release, the company said “all key Novartis medicines for US patients will be made in the United States.”
“As a Swiss-based company with a significant
Continue reading
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!